Forbes September 24, 2024
Anuradha Varanasi

Most commonly, doctors prescribe a type of antidepressant known as selective serotonin reuptake inhibitors (SSRIs) for treating depressive symptoms. But while SSRI antidepressants can help in offering relief from symptoms, in comparison, psilocybin or magic mushrooms might be more effective, according to a recent study.

Co-first author of the study, David Erritzoe, Clinical Director and Deputy Head of the Centre for Psychedelic Research, Imperial College, London, said in a press release: “This is important because improving connectedness and having greater meaning in life can significantly enhance a person’s quality of life and long-term mental health.”

“The study suggests that psilocybin therapy might be a more holistic treatment option for depression, addressing both the symptoms of depression and overall well-being. This...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mental Health, Provider, Survey / Study, Trends
Australia infuses $85M in digital mental health and more briefs
After Reaching Profitability, Talkspace Hints at M&A
Headline Risk May Shift JV Market Away from For-Profit Operators
Youth mental health needs keep growing — here's how this provider is responding
The Ongoing Movement Against Psychiatric Medications

Share This Article